NYMC Faculty Publications
Chapter 9 - COVID-19 Vaccines for High Risk and Immunocompromised Patients
Author Type(s)
Faculty
DOI
10.1016/bs.mim.2021.11.001
Journal Title
Methods in Microbiology
First Page
269
Last Page
279
Document Type
Book Chapter
Publication Date
2022
Department
Medicine
Abstract
The availability of multiple versions of vaccines designed to help prevent COVID-19 has offered an opportunity to at least control the current pandemic, and possibly to quickly eradicate this disease fully, along with the implementation of other preventive measures. In order to accomplish this feat more effectively, as many people as possible need to be vaccinated, especially for high-risk groups having co-morbid conditions such as diabetes, obesity and old age, and possibly those with various forms of immunodeficiencies, such as HIV/AIDS. This chapter focuses primarily on some of the basic biomedical aspects on vaccine design and use, and any possible concerns that need to be considered in getting people in the high-risk category vaccinated and monitored thereafter for their continuous health and well-being.
Recommended Citation
Pavia, C. S., & Plummer, M. M. (2022). Chapter 9 - COVID-19 Vaccines for High Risk and Immunocompromised Patients. Methods in Microbiology, 50, 269-279. https://doi.org/10.1016/bs.mim.2021.11.001
